针对TEAD-ious的阻力
Connor A Ott1, Andrew E Aplin2
1Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Trends in cancer
|August 5, 2023
概括
通过向TEAD转录因子,可以克服对KRAS抑制剂的耐药性. 一种新的TEAD抑制剂GNE-7883可能会提高癌症患者的KRAS抑制剂的耐用性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向KRAS突变是癌症治疗的一个关键策略.
- 对KRAS抑制剂的耐药性仍然是一个重大的临床挑战.
- 该KRAS信号通路对于癌细胞的增殖和生存至关重要.
研究的目的:
- 研究向TEAD转录因子以克服对KRAS抑制剂的耐药性的潜力.
- 在临床前癌症模型中评估一种新型TEAD抑制剂GNE-7883的疗效.
- 探索TEAD在调解对KRAS向疗法的耐药性的作用.
主要方法:
- 使用了一种新型抑制剂GNE-7883,向TEAD转录因子.
- 在相关的癌症模型中进行了研究,显示了KRAS突变和耐药性.
- 评估GNE-7883对KRAS信号通路和瘤生长的影响.
主要成果:
- GNE-7883在克服对现有KRAS抑制剂的耐药性方面表现出有效性.
- 通过GNE-7883抑制TEAD信号传递显示出抗瘤活性.
- 该研究提供了结合KRAS和TEAD抑制剂的治疗潜力的证据.
结论:
- 像GNE-7883这样的TEAD抑制剂是提高KRAS抑制剂耐久性的有希望的策略.
- 向TEAD转录因子可以克服癌症中对KRAS向疗法的获得性耐药性.
- 对于KRAS突变癌症患者,需要对TEAD抑制剂进行进一步的临床研究.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Transduction
42
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
42
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


